Literature DB >> 1281698

[Brain metastasis of choriocarcinoma in males. Apropos of a case. Review of the literature].

C Soussain1, P Michel-Langlet, M Mahjoubi, M J Terrier-Lacombe, J P Droz.   

Abstract

A 22 year-old male patient had a choriocarcinoma of the mediastinum metastatic to the brain, liver, lung and skin. He was treated with five cycles of chemotherapy containing cisplatinum, vinblastine, VP16 and bleomycin and he achieved a partial remission. Then he developed a progressive disease exclusively located to the brain and he died of an intracranial hemorrhage. The autopsy showed the mediastinum and the lung being free of residual trophoblastic tumor. Pure choriocarcinoma is rare in males, but brain metastases are frequently present in this case. Therapeutic guidelines are uncertain, so they must refer to the experience obtained in gestational choriocarcinoma. Two groups of patients are individualized both in male germ cell tumors and in placental choriocarcinoma: one group of patients with brain metastases at diagnosis, with a better prognosis, and one group of patients with brain metastases occurring in the course of the disease, with a poor outcome. The risk of intratumoral hemorrhage is common to all varieties of choriocarcinoma brain metastases and is not lowered by greater effectiveness of the chemotherapy. Brain metastases found at the moment of the choriocarcinoma diagnosis require chemotherapy and radiotherapy and in some selected cases, a surgical removal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281698

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

Review 1.  Testicular choriocarcinoma: a rare variant that requires a unique treatment approach.

Authors:  Matthew James Reilley; Lance C Pagliaro
Journal:  Curr Oncol Rep       Date:  2015-02       Impact factor: 5.075

2.  Male primary mediastinal choriocarcinoma with diffuse metastases: A case report.

Authors:  Zhenhua Qiu; Yuanqiang Wu; Yapeng Wang; Chunhong Hu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.